Terms: = Ovarian cancer AND RARA, RAR, 5914, ENSG00000131759, NR1B1
46 results:
1. Expression of selected nuclear receptors in human epithelial ovarian cell line Caov3 exposed to bisphenol derivatives.
Mlynarcikova AB; Macejova D; Scsukova S
Endocr Regul; 2023 Jan; 57(1):191-199. PubMed ID: 37715983
[No Abstract] [Full Text] [Related]
2. Targeting the Retinoic Acid Pathway to Eradicate cancer Stem Cells.
Brown G
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768694
[TBL] [Abstract] [Full Text] [Related]
3. Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer.
Li Y; Jaiswal SK; Kaur R; Alsaadi D; Liang X; Drews F; DeLoia JA; Krivak T; Petrykowska HM; Gotea V; Welch L; Elnitski L
BMC Cancer; 2021 Jul; 21(1):768. PubMed ID: 34215221
[TBL] [Abstract] [Full Text] [Related]
4. Characterization of therapy-related acute leukemia in hereditary breast-ovarian carcinoma patients: role of BRCA1 mutation and topoisomerase II-directed therapy.
Bagal B; Kumar R; Gaur T; Talreja V; Bonda A; Patkar N; Shetty D; Kowtal P; Subramanian PG; Gupta S; Sarin R; Hasan SK
Med Oncol; 2020 Apr; 37(5):48. PubMed ID: 32277283
[TBL] [Abstract] [Full Text] [Related]
5. Long noncoding RNA WDFY3-AS2 suppresses tumor progression by acting as a competing endogenous RNA of microRNA-18a in ovarian cancer.
Li W; Ma S; Bai X; Pan W; Ai L; Tan W
J Cell Physiol; 2020 Feb; 235(2):1141-1154. PubMed ID: 31347170
[TBL] [Abstract] [Full Text] [Related]
6. Association between RAD51 135 G/C polymorphism and risk of 3 common gynecological cancers: A meta-analysis.
Zeng X; Zhang Y; Yang L; Xu H; Zhang T; An R; Zhu K
Medicine (Baltimore); 2018 Jun; 97(26):e11251. PubMed ID: 29952992
[TBL] [Abstract] [Full Text] [Related]
7. Inhibition of cancer stem cell like cells by a synthetic retinoid.
Chen J; Cao X; An Q; Zhang Y; Li K; Yao W; Shi F; Pan Y; Jia Q; Zhou W; Yang F; Wei F; Wang N; Yu B
Nat Commun; 2018 Apr; 9(1):1406. PubMed ID: 29643385
[TBL] [Abstract] [Full Text] [Related]
8. Cellular retinoid binding-proteins, CRBP, CRABP, FABP5: Effects on retinoid metabolism, function and related diseases.
Napoli JL
Pharmacol Ther; 2017 May; 173():19-33. PubMed ID: 28132904
[TBL] [Abstract] [Full Text] [Related]
9. Age-related differences in the sonographic characteristics of endometriomas.
Guerriero S; Van Calster B; Somigliana E; Ajossa S; Froyman W; De Cock B; Coosemans A; Fischerová D; Van Holsbeke C; Alcazar JL; Testa AC; Valentin L; Bourne T; Timmerman D
Hum Reprod; 2016 Aug; 31(8):1723-31. PubMed ID: 27282774
[TBL] [Abstract] [Full Text] [Related]
10. Retinoic acid receptors: from molecular mechanisms to cancer therapy.
di Masi A; Leboffe L; De Marinis E; Pagano F; Cicconi L; Rochette-Egly C; Lo-Coco F; Ascenzi P; Nervi C
Mol Aspects Med; 2015 Feb; 41():1-115. PubMed ID: 25543955
[TBL] [Abstract] [Full Text] [Related]
11. Epigenetic alteration of p16 and retinoic acid receptor beta genes in the development of epithelial ovarian carcinoma.
Bhagat R; Kumar SS; Vaderhobli S; Premalata CS; Pallavi VR; Ramesh G; Krishnamoorthy L
Tumour Biol; 2014 Sep; 35(9):9069-78. PubMed ID: 24913706
[TBL] [Abstract] [Full Text] [Related]
12. [Methylation of promoter region of rar-beta2 gene in renal cell, breast, and ovarian carcinomas].
Khodyrev DS; Loginov VI; Pronina IV; Kazubskaia TP; Gar'kavtseva RF; Braga EA
Genetika; 2008 Aug; 44(8):1126-32. PubMed ID: 18825962
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of Her-2/neu status in carcinomas with amplified chromosome 17 centromere locus.
Troxell ML; Bangs CD; Lawce HJ; Galperin IB; Baiyee D; West RB; Olson SB; Cherry AM
Am J Clin Pathol; 2006 Nov; 126(5):709-16. PubMed ID: 17050068
[TBL] [Abstract] [Full Text] [Related]
14. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
Liu WJ; Wang L; Wang JP; Li JQ; Zhang CQ; Zheng L; Yuan YF
Ai Zheng; 2006 Jun; 25(6):696-700. PubMed ID: 16764763
[TBL] [Abstract] [Full Text] [Related]
15. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
[TBL] [Abstract] [Full Text] [Related]
16. Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists.
Benbrook DM; Kamelle SA; Guruswamy SB; Lightfoot SA; Rutledge TL; Gould NS; Hannafon BN; Dunn ST; Berlin KD
Invest New Drugs; 2005 Oct; 23(5):417-28. PubMed ID: 16133793
[TBL] [Abstract] [Full Text] [Related]
17. An EGF receptor inhibitor induces rar-beta expression in breast and ovarian cancer cells.
Grunt TW; Puckmair K; Tomek K; Kainz B; Gaiger A
Biochem Biophys Res Commun; 2005 Apr; 329(4):1253-9. PubMed ID: 15766561
[TBL] [Abstract] [Full Text] [Related]
18. Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.
Villani MG; Appierto V; Cavadini E; Valsecchi M; Sonnino S; Curley RW; Formelli F
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6265-75. PubMed ID: 15448016
[TBL] [Abstract] [Full Text] [Related]
19. Promoter hypermethylation of MGMT, CDH1, rar-beta and SYK tumour suppressor genes in granulosa cell tumours (GCTs) of ovarian origin.
Dhillon VS; Young AR; Husain SA; Aslam M
Br J Cancer; 2004 Feb; 90(4):874-81. PubMed ID: 14970867
[TBL] [Abstract] [Full Text] [Related]
20. Potent cytotoxic effects of novel retinamide derivatives in ovarian cancer cells.
Um SJ; Sin HS; Han HS; Kwon YJ; Kim EJ; Park SH; Kim SY; Bae TS; Park JS; Rho YS
Biol Pharm Bull; 2003 Oct; 26(10):1412-7. PubMed ID: 14519946
[TBL] [Abstract] [Full Text] [Related]
[Next]
